Collegium Pharmaceutical Stock Intrinsic Value – Collegium Pharmaceutical Shares Soar on Record 2024 Adjusted EBITDA Outlook
☀️Trending News COLLEGIUM PHARMACEUTICAL ($NASDAQ:COLL) is a specialty pharmaceutical company focused on developing and commercializing innovative, proprietary products designed to [...]
COLLEGIUM PHARMACEUTICAL Reports Third Quarter Earnings for Fiscal Year 2023
🌥️Earnings Overview COLLEGIUM PHARMACEUTICAL ($NASDAQ:COLL) reported total revenue of USD 136.7 million for the third quarter of fiscal year 2023, [...]
COLLEGIUM PHARMACEUTICAL Reports Q2 FY2023 Earnings Results on August 3 2023
🌥️Earnings Overview On August 3 2023, COLLEGIUM PHARMACEUTICAL ($NASDAQ:COLL) reported its earnings results for the second quarter of FY2023, ending [...]
COLLEGIUM PHARMACEUTICAL Reports Second Quarter FY2023 Earnings Results on August 3 2023
🌥️Earnings Overview COLLEGIUM PHARMACEUTICAL ($NASDAQ:COLL) released their earnings for the second quarter of 2023 (ending June 30th, 2023) on August [...]
Collegium Pharmaceutical Intrinsic Value – Needham Reiterates Buy Recommendation for Collegium Pharmaceutical on May 5, 2023.
Trending News 🌥️ On May 5, 2023, Needham reiterated its Buy rating for Collegium Pharmaceutical ($NASDAQ:COLL), according to Fintel. Needham [...]
Collegium Pharmaceutical Reports Higher-Than-Expected Revenue But Misses Non-GAAP EPS Estimate
Trending News 🌧️ The specialty pharmaceutical company reported a Non-GAAP EPS of $1.32, which was $0.19 lower than expected, and [...]
k.a. “the leader in abuse-deterrent technology,” is no exception.
Trending News 🌧️ Collegium Pharmaceutical ($NASDAQ:COLL), Inc., is a pioneering force in the pharmaceutical industry, renowned for its innovative solutions [...]
Collegium Pharmaceutical Intrinsic Value – COLLEGIUM PHARMACEUTICAL Demonstrates Commitment to Patient Safety with Updated FDA Opioid Regulations
Trending News ☀️ COLLEGIUM PHARMACEUTICAL ($NASDAQ:COLL) is a specialty pharmaceutical company focused on developing and commercializing innovative treatments that improve [...]
Yousif Capital Management LLC Rebalances Portfolio with Sale of 8300 Collegium Pharmaceutical, Shares
Trending News ☀️ Collegium Pharmaceutical ($NASDAQ:COLL), Inc. has recently had 8300 of its shares sold by Yousif Capital Management LLC, [...]
Needham Reaffirms Buy on Collegium Pharmaceutical, Retains $35 Price Target
Trending News 🌥️ Needham, a leading investment banking firm, has recently reaffirmed its "buy" rating on Collegium Pharmaceutical ($NASDAQ:COLL) Inc.'s [...]
